Financial Gravity Asset Management, Inc. Exact Sciences Corp Transaction History

Financial Gravity Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$56.27 - $73.77 $2,644 - $3,467	47 Added 1566.67%	50 $3.51 Million
Q4 2023 Jun 26, 2024	SELL	$59.06 - $75.72 $2,775 - $3,558	-47 Reduced 94.0%	3 $255,000
Q3 2023 Nov 15, 2023	SELL	$65.94 - $99.04 $6,000 - $9,012	-91 Reduced 96.81%	3 $0
Q2 2023 Aug 08, 2023	BUY	$62.68 - $95.05 $5,891 - $8,934	94 New	94 $9.25 Million
Q4 2022 Feb 15, 2023	BUY	$30.35 - $53.15 $1,517 - $2,657	50 New	50 $38,000
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $167 - $278	-3 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$37.9 - $104.44 $113 - $313	3 New	3 $0

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.